Blansko, Czechia

Ondrej Hylse

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Synthon B.v.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ondrej Hylse. Retrieved from https://idiyas.com/inventor/ondrej-hylse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ondrej Hylse: Innovator in Pharmaceutical Processes

Introduction

Ondrej Hylse is a notable inventor based in Blansko, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug synthesis. His work is characterized by a focus on innovative methods that enhance the efficiency and effectiveness of pharmaceutical compounds.

Latest Patents

Hylse holds a patent for a process for making Siponimod and its intermediates. The presented invention relates to a process for the preparation of a compound of formula (I) or a salt or a solvate thereof, specifically Siponimod. This invention also encompasses the intermediates used in the process and the solid forms of these intermediates. His patent is a testament to his expertise in pharmaceutical chemistry and innovation.

Career Highlights

Hylse is associated with Synthon B.V., a company known for its commitment to developing high-quality pharmaceuticals. His role at Synthon B.V. allows him to apply his inventive skills in a collaborative environment, contributing to the advancement of pharmaceutical technologies.

Collaborations

Throughout his career, Hylse has worked alongside esteemed colleagues such as Rolf Keltjens and Jiri Partl. These collaborations have fostered a productive exchange of ideas and expertise, further enhancing the impact of their collective work in the pharmaceutical industry.

Conclusion

Ondrej Hylse's contributions to the field of pharmaceuticals through his innovative processes exemplify the importance of invention in advancing medical science. His work not only reflects his personal dedication to innovation but also highlights the collaborative spirit of the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…